The objectives of this proposal are to characterize the pathological roles of AEP-cleaved APP and AEP-cleaved Tau fragments in Alzheimer's disease (AD) onset and progression and how AEP is molecularly regulated during ageing. AEP is an acidosis-activated protease with a high level of specificity for cleavage of protein substrates after an asparagine residue. AD is characterized by the accumulation of the ?-amyloid peptide (A?) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein Tau. Endogenous AEP is inhibited by Cystatin E/M, an A?-associated protein, preventing neurodegeneration in AD. Most recently, we show that AEP is activated by A? and cleaves APP and Tau in human AD brains and mediates AD pathology. Notably, AEP is expressed in brain and spinal cord in an age-dependent manner. We found that AEP upregulation and activation tightly correlate with APP and Tau fragmentation during ageing. Strikingly, we found that C/EBP?, an age-dependent transcription factor, plays a critical role in regulating AEP expression during ageing. Hence, we hypothesize that AEP may play a critical role in mediating AD pathogenesis, which is mediated by C/EBP?. Successful completion of the proposed studies will lead to the identification of a novel drug target for treatment of neurodegenerative diseases including AD.

Public Health Relevance

Asparagine endopeptidase (AEP) is upregulated and activated in brain during ageing, leading to degradation of APP and Tau in an age-dependent manner. AEP is selectively activated in human AD brains versus healthy controls, indicating that AEP is a novel proteinase distinguished from the well-known secretases or caspases. Successful completion of the proposed studies will lead to the identification of a novel drug target for treatment of neurodegenerative diseases including AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Multi-Year Funded Research Project Grant (RF1)
Project #
1RF1AG051538-01A1
Application #
9172834
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Yang, Austin Jyan-Yu
Project Start
2016-08-01
Project End
2021-06-30
Budget Start
2016-08-01
Budget End
2021-06-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Bao, Jian; Qin, Min; Mahaman, Yacoubou Abdoul Razak et al. (2018) BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease. Proc Natl Acad Sci U S A 115:3954-3959
Wang, Zhi-Hao; Gong, Ke; Liu, Xia et al. (2018) C/EBP? regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease. Nat Commun 9:1784
Kang, Seong Su; Ahn, Eun Hee; Zhang, Zhentao et al. (2018) ?-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease. EMBO J 37:
Chen, Chun; Wang, Zhihao; Zhang, Zhentao et al. (2018) The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease. Proc Natl Acad Sci U S A 115:578-583
Wang, Zhi-Hao; Liu, Pai; Liu, Xia et al. (2018) Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies. J Exp Med 215:3038-3056
Wang, Zhi-Hao; Wu, Wanqiang; Kang, Seong Su et al. (2018) BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3:
Tse, Margaret Chui Ling; Herlea-Pana, Oana; Brobst, Daniel et al. (2017) Tumor Necrosis Factor-? Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle. Diabetes 66:1858-1870
Qi, Qi; Obianyo, Obiamaka; Du, Yuhong et al. (2017) Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis. J Med Chem 60:7244-7255
Qi, Q; Kang, S S; Zhang, S et al. (2017) Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression. Oncogene 36:4562-4572
Lin, Quan; Ponnusamy, Ravikumar; Widagdo, Jocelyn et al. (2017) MicroRNA-mediated disruption of dendritogenesis during a critical period of development influences cognitive capacity later in life. Proc Natl Acad Sci U S A 114:9188-9193

Showing the most recent 10 out of 18 publications